Plaintiffs' Request To Reinstate 13 Risperdal Cases

Plaintiffs' Request To Reinstate 13 Risperdal Cases

Introduction

Plaintiffs' request to reinstate 13 Risperdal gynecomastia cases was denied by a Pennsylvania state appeals panel agreeing with the trial judge that the claims were preempted by Michigan's drug shield law and that the plaintiffs could not prove that the fraud exception applied to their claims. Janssen Pharmaceuticals Inc. is the defendant named in this litigation.